Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 45

1.

Charting the peptide crossreactome between HIV-1 and the human proteome.

Lucchese G, Stufano A, Calabro M, Kanduc D.

Front Biosci (Elite Ed). 2011 Jun 1;3:1385-400.

PMID:
21622144
2.

Clustering of rare peptide segments in the HCV immunome.

Stufano A, Capone G, Pesetti B, Polimeno L, Kanduc D.

Self Nonself. 2010 Apr;1(2):154-162. Epub 2010 Feb 3.

3.

The self/nonself issue: A confrontation between proteomes.

Kanduc D.

Self Nonself. 2010 Jul;1(3):255-258. Epub 2010 Jan 29.

4.
5.

Human immunodeficiency virus-1 vaccine design: where do we go now?

Wijesundara DK, Jackson RJ, Ramshaw IA, Ranasinghe C.

Immunol Cell Biol. 2011 Mar;89(3):367-74. doi: 10.1038/icb.2010.118. Epub 2010 Oct 19. Review.

PMID:
20956986
6.

Proposing low-similarity peptide vaccines against Mycobacterium tuberculosis.

Lucchese G, Stufano A, Kanduc D.

J Biomed Biotechnol. 2010;2010:832341. doi: 10.1155/2010/832341. Epub 2010 Jun 3.

7.

4E10-resistant HIV-1 isolated from four subjects with rare membrane-proximal external region polymorphisms.

Nakamura KJ, Gach JS, Jones L, Semrau K, Walter J, Bibollet-Ruche F, Decker JM, Heath L, Decker WD, Sinkala M, Kankasa C, Thea D, Mullins J, Kuhn L, Zwick MB, Aldrovandi GM.

PLoS One. 2010 Mar 23;5(3):e9786. doi: 10.1371/journal.pone.0009786.

8.

Is an HIV vaccine possible?

Wilson NA, Watkins DI.

Braz J Infect Dis. 2009 Aug;13(4):304-10. Review.

9.

Protein information content resides in rare peptide segments.

Kanduc D.

Peptides. 2010 May;31(5):983-8. doi: 10.1016/j.peptides.2010.02.003. Epub 2010 Feb 11. Review.

PMID:
20153390
10.

ON THE SEROLOGICAL SPECIFICITY OF PEPTIDES. III.

Landsteiner K, van der Scheer J.

J Exp Med. 1939 Apr 30;69(5):705-19.

11.

"Self-nonself" peptides in the design of vaccines.

Kanduc D.

Curr Pharm Des. 2009;15(28):3283-9. Review.

PMID:
19860677
12.

The Universal Protein Resource (UniProt) in 2010.

UniProt Consortium..

Nucleic Acids Res. 2010 Jan;38(Database issue):D142-8. doi: 10.1093/nar/gkp846. Epub 2009 Oct 20.

13.

Roadblocks in HIV research: five questions.

Thomas C.

Nat Med. 2009 Aug;15(8):855-9. doi: 10.1038/nm0809-855. No abstract available.

PMID:
19661992
14.

HIV vaccine development: Lessons from the past, informing the future.

Bradac J, Dieffenbach CW.

IDrugs. 2009 Jul;12(7):435-9. Review.

PMID:
19579164
15.

Proteome-based epitopic peptide scanning along PSA.

Stufano A, Kanduc D.

Exp Mol Pathol. 2009 Feb;86(1):36-40. doi: 10.1016/j.yexmp.2008.11.009. Epub 2008 Dec 9.

PMID:
19109947
16.

Immunogenicity in peptide-immunotherapy: from self/nonself to similar/dissimilar sequences.

Kanduc D.

Adv Exp Med Biol. 2008;640:198-207. doi: 10.1007/978-0-387-09789-3_15. Review.

PMID:
19065793
17.

Epitopic peptides with low similarity to the host proteome: towards biological therapies without side effects.

Kanduc D.

Expert Opin Biol Ther. 2009 Jan;9(1):45-53. doi: 10.1517/14712590802614041 . Review.

PMID:
19063692
18.

Viral sequence diversity: challenges for AIDS vaccine designs.

McBurney SP, Ross TM.

Expert Rev Vaccines. 2008 Nov;7(9):1405-17. doi: 10.1586/14760584.7.9.1405. Review.

19.

Massive peptide sharing between viral and human proteomes.

Kanduc D, Stufano A, Lucchese G, Kusalik A.

Peptides. 2008 Oct;29(10):1755-66. doi: 10.1016/j.peptides.2008.05.022. Epub 2008 Jun 5.

PMID:
18582510
20.

The hunt for an HIV vaccine: time to rethink recent failures.

Boasso A, Shearer GM, Clerici M.

Lancet. 2008 Jun 7;371(9628):1897-8. doi: 10.1016/S0140-6736(08)60812-0. No abstract available.

PMID:
18539209

Supplemental Content

Support Center